rlyb116
rlyb116: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Rallybio Corp (RLYB) | Phase 1 |
Clinical Trials (1)
Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RLYB116 in Healthy Participants
Frequently asked questions
Who is developing rlyb116?
rlyb116 is being developed by Rallybio Corp.
How many clinical trials involve rlyb116?
BioSniper tracks 1 clinical trial involving rlyb116.
Get deeper analysis on rlyb116
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis